231 related articles for article (PubMed ID: 21228231)
1. The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.
Lubinski JM; Lazear HM; Awasthi S; Wang F; Friedman HM
J Virol; 2011 Apr; 85(7):3239-49. PubMed ID: 21228231
[TBL] [Abstract][Full Text] [Related]
2. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.
Nagashunmugam T; Lubinski J; Wang L; Goldstein LT; Weeks BS; Sundaresan P; Kang EH; Dubin G; Friedman HM
J Virol; 1998 Jul; 72(7):5351-9. PubMed ID: 9620988
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus type 1 evades the effects of antibody and complement in vivo.
Lubinski JM; Jiang M; Hook L; Chang Y; Sarver C; Mastellos D; Lambris JD; Cohen GH; Eisenberg RJ; Friedman HM
J Virol; 2002 Sep; 76(18):9232-41. PubMed ID: 12186907
[TBL] [Abstract][Full Text] [Related]
4. Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor.
Lin X; Lubinski JM; Friedman HM
J Virol; 2004 Mar; 78(5):2562-71. PubMed ID: 14963159
[TBL] [Abstract][Full Text] [Related]
5. Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.
Awasthi S; Huang J; Shaw C; Friedman HM
J Virol; 2014 Aug; 88(15):8421-32. PubMed ID: 24829358
[TBL] [Abstract][Full Text] [Related]
6. Immune evasion by herpes simplex virus type 1, strategies for virus survival.
Friedman HM
Trans Am Clin Climatol Assoc; 2003; 114():103-12. PubMed ID: 12813914
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease.
Saldanha CE; Lubinski J; Martin C; Nagashunmugam T; Wang L; van Der Keyl H; Tal-Singer R; Friedman HM
J Virol; 2000 Aug; 74(15):6712-9. PubMed ID: 10888608
[TBL] [Abstract][Full Text] [Related]
8. Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine.
Awasthi S; Lubinski JM; Friedman HM
Vaccine; 2009 Nov; 27(49):6845-53. PubMed ID: 19761834
[TBL] [Abstract][Full Text] [Related]
9. A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus.
Ramsey NLM; Visciano M; Hunte R; Loh LN; Burn Aschner C; Jacobs WR; Herold BC
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295919
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells.
Dingwell KS; Brunetti CR; Hendricks RL; Tang Q; Tang M; Rainbow AJ; Johnson DC
J Virol; 1994 Feb; 68(2):834-45. PubMed ID: 8289387
[TBL] [Abstract][Full Text] [Related]
11. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
Hook LM; Huang J; Jiang M; Hodinka R; Friedman HM
J Virol; 2008 Jul; 82(14):6935-41. PubMed ID: 18480440
[TBL] [Abstract][Full Text] [Related]
12. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC.
Lubinski J; Wang L; Mastellos D; Sahu A; Lambris JD; Friedman HM
J Exp Med; 1999 Dec; 190(11):1637-46. PubMed ID: 10587354
[TBL] [Abstract][Full Text] [Related]
13. Viral interference with antibody and complement.
Lubinski J; Nagashunmugam T; Friedman HM
Semin Cell Dev Biol; 1998 Jun; 9(3):329-37. PubMed ID: 9665870
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
15. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
Peng T; Ponce-de-Leon M; Jiang H; Dubin G; Lubinski JM; Eisenberg RJ; Cohen GH
J Virol; 1998 Jan; 72(1):65-72. PubMed ID: 9420201
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms.
Chu CF; Meador MG; Young CG; Strasser JE; Bourne N; Milligan GN
J Reprod Immunol; 2008 Jun; 78(1):58-67. PubMed ID: 17950908
[TBL] [Abstract][Full Text] [Related]
17. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.
Krawczyk A; Krauss J; Eis-Hübinger AM; Däumer MP; Schwarzenbacher R; Dittmer U; Schneweis KE; Jäger D; Roggendorf M; Arndt MA
J Virol; 2011 Feb; 85(4):1793-803. PubMed ID: 21123390
[TBL] [Abstract][Full Text] [Related]
18. Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2.
Kao CM; Goymer J; Loh LN; Mahant A; Burn Aschner C; Herold BC
J Infect Dis; 2020 Feb; 221(5):729-738. PubMed ID: 31599942
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus antagonizes activation of Fcγ receptors by distinct and synergizing modes of IgG manipulation.
Kolb P; Hoffmann K; Sievert A; Reinhard H; Merce-Maldonado E; Le-Trilling VTK; Halenius A; Gütle D; Hengel H
Elife; 2021 Mar; 10():. PubMed ID: 33724188
[TBL] [Abstract][Full Text] [Related]
20. UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I.
Ng TI; Ogle WO; Roizman B
Virology; 1998 Feb; 241(1):37-48. PubMed ID: 9454715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
